Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
Add to list
  1. Search results
  2. Seven novel modulators of the analges...

Seven novel modulators of the analgesic target Nav1.7 uncovered using a high-throughput venom-based discovery approach

Julie K Klint, Jennifer J Smith, Irina Vetter, Darshani B Rupasinghe, Sing Yan Er, Sebastian Senff, Volker Herzig, Mehdi Mobli, Richard J Lewis, Frank Bosmans (UGent) , et al.
(2015) Br J Pharmacol. 172(10). p.2445-2458
Author
Organization
Abstract
Background and Purpose: Chronic pain is a serious worldwide health issue, with current analgesics having limited efficacy and dose-limiting side effects. Humans with loss-of-function mutations in the voltage-gated sodium channel Na(V)1.7 (hNa(V)1.7) are indifferent to pain, making hNa(V)1.7 a promising target for analgesic development. Since spider venoms are replete with Na-V channel modulators, we examined their potential as a source of hNa(V)1.7 inhibitors. Experimental Approach: We developed a high-throughput fluorescent-based assay to screen spider venoms against hNa(V)1.7 and isolate hit' peptides. To examine the binding site of these peptides, we constructed a panel of chimeric channels in which the S3b-S4 paddle motif from each voltage sensor domain of hNa(V)1.7 was transplanted into the homotetrameric K(V)2.1 channel. Key Results: We screened 205 spider venoms and found that 40% contain at least one inhibitor of hNa(V)1.7. By deconvoluting hit' venoms, we discovered seven novel members of the NaSpTx family 1. One of these peptides, Hd1a (peptide -TRTX-Hd1a from venom of the spider Haplopelma doriae), inhibited hNa(V)1.7 with a high level of selectivity over all other subtypes, except hNa(V)1.1. We showed that Hd1a is a gating modifier that inhibits hNa(V)1.7 by interacting with the S3b-S4 paddle motif in channel domain II. The structure of Hd1a, determined using heteronuclear NMR, contains an inhibitor cystine knot motif that is likely to confer high levels of chemical, thermal and biological stability. Conclusion and Implications: Our data indicate that spider venoms are a rich natural source of hNa(V)1.7 inhibitors that might be useful leads for the development of novel analgesics.
Keywords
GATED SODIUM-CHANNELS, EXTREME PAIN DISORDER, SHAKER K+ CHANNEL, CA-V CHANNELS, VOLTAGE-SENSOR, HUWENTOXIN-IV, PEPTIDE TOXINS, ION CHANNELS, NUCLEOTIDE POLYMORPHISM, DOMAIN-II

Citation

Please use this url to cite or link to this publication:

MLA
Klint, Julie K., et al. “Seven Novel Modulators of the Analgesic Target Nav1.7 Uncovered Using a High-Throughput Venom-Based Discovery Approach.” Br J Pharmacol, vol. 172, no. 10, 2015, pp. 2445–58, doi:10.1111/bph.13081.
APA
Klint, J. K., Smith, J. J., Vetter, I., Rupasinghe, D. B., Er, S. Y., Senff, S., … King, G. F. (2015). Seven novel modulators of the analgesic target Nav1.7 uncovered using a high-throughput venom-based discovery approach. Br J Pharmacol, 172(10), 2445–2458. https://doi.org/10.1111/bph.13081
Chicago author-date
Klint, Julie K, Jennifer J Smith, Irina Vetter, Darshani B Rupasinghe, Sing Yan Er, Sebastian Senff, Volker Herzig, et al. 2015. “Seven Novel Modulators of the Analgesic Target Nav1.7 Uncovered Using a High-Throughput Venom-Based Discovery Approach.” Br J Pharmacol 172 (10): 2445–58. https://doi.org/10.1111/bph.13081.
Chicago author-date (all authors)
Klint, Julie K, Jennifer J Smith, Irina Vetter, Darshani B Rupasinghe, Sing Yan Er, Sebastian Senff, Volker Herzig, Mehdi Mobli, Richard J Lewis, Frank Bosmans, and Glenn F King. 2015. “Seven Novel Modulators of the Analgesic Target Nav1.7 Uncovered Using a High-Throughput Venom-Based Discovery Approach.” Br J Pharmacol 172 (10): 2445–2458. doi:10.1111/bph.13081.
Vancouver
1.
Klint JK, Smith JJ, Vetter I, Rupasinghe DB, Er SY, Senff S, et al. Seven novel modulators of the analgesic target Nav1.7 uncovered using a high-throughput venom-based discovery approach. Br J Pharmacol. 2015;172(10):2445–58.
IEEE
[1]
J. K. Klint et al., “Seven novel modulators of the analgesic target Nav1.7 uncovered using a high-throughput venom-based discovery approach,” Br J Pharmacol, vol. 172, no. 10, pp. 2445–2458, 2015.
@article{8584514,
  abstract     = {{Background and Purpose: Chronic pain is a serious worldwide health issue, with current analgesics having limited efficacy and dose-limiting side effects. Humans with loss-of-function mutations in the voltage-gated sodium channel Na(V)1.7 (hNa(V)1.7) are indifferent to pain, making hNa(V)1.7 a promising target for analgesic development. Since spider venoms are replete with Na-V channel modulators, we examined their potential as a source of hNa(V)1.7 inhibitors. 
Experimental Approach: We developed a high-throughput fluorescent-based assay to screen spider venoms against hNa(V)1.7 and isolate hit' peptides. To examine the binding site of these peptides, we constructed a panel of chimeric channels in which the S3b-S4 paddle motif from each voltage sensor domain of hNa(V)1.7 was transplanted into the homotetrameric K(V)2.1 channel. 
Key Results: We screened 205 spider venoms and found that 40% contain at least one inhibitor of hNa(V)1.7. By deconvoluting hit' venoms, we discovered seven novel members of the NaSpTx family 1. One of these peptides, Hd1a (peptide -TRTX-Hd1a from venom of the spider Haplopelma doriae), inhibited hNa(V)1.7 with a high level of selectivity over all other subtypes, except hNa(V)1.1. We showed that Hd1a is a gating modifier that inhibits hNa(V)1.7 by interacting with the S3b-S4 paddle motif in channel domain II. The structure of Hd1a, determined using heteronuclear NMR, contains an inhibitor cystine knot motif that is likely to confer high levels of chemical, thermal and biological stability. 
Conclusion and Implications: Our data indicate that spider venoms are a rich natural source of hNa(V)1.7 inhibitors that might be useful leads for the development of novel analgesics.}},
  author       = {{Klint, Julie K and Smith, Jennifer J and Vetter, Irina and Rupasinghe, Darshani B and Er, Sing Yan and Senff, Sebastian and Herzig, Volker and Mobli, Mehdi and Lewis, Richard J and Bosmans, Frank and King, Glenn F}},
  issn         = {{0007-1188}},
  journal      = {{Br J Pharmacol}},
  keywords     = {{GATED SODIUM-CHANNELS,EXTREME PAIN DISORDER,SHAKER K+ CHANNEL,CA-V CHANNELS,VOLTAGE-SENSOR,HUWENTOXIN-IV,PEPTIDE TOXINS,ION CHANNELS,NUCLEOTIDE POLYMORPHISM,DOMAIN-II}},
  language     = {{eng}},
  number       = {{10}},
  pages        = {{2445--2458}},
  title        = {{Seven novel modulators of the analgesic target Nav1.7 uncovered using a high-throughput venom-based discovery approach}},
  url          = {{http://doi.org/10.1111/bph.13081}},
  volume       = {{172}},
  year         = {{2015}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: